The landscape of dementia prognosis has evolved drastically with the advent of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based assessments that could detect Alzheimer's pathology a long time prior to symptoms arise. Even though these technological developments represent extraordinary development in knowing neurodegenerative diseases, they https://chandrak319itd9.iyublog.com/profile